PURPOSE: Elevation of long-chain acylcarnitine levels is a hallmark of long-chain mitochondrial β-oxidation (FAO) disorders, and can be accompanied by secondary carnitine deficiency. To restore free carnitine levels, and to increase myocardial export of long-chain fatty acyl-CoA esters, supplementation of L-carnitine in patients has been proposed. However, carnitine supplementation is controversial, because it may enhance the potentially lipotoxic buildup of long-chain acylcarnitines in the FAO-deficient heart. In this longitudinal study, we investigated the effects of carnitine supplementation in an animal model of long-chain FAO deficiency, the long-chain acyl-CoA dehydrogenase (LCAD) knockout (KO) mouse. METHODS: Cardiac size and function, and triglyceride (TG) levels were quantified using proton magnetic resonance imaging (MRI) and spectroscopy ((1)H-MRS) in LCAD KO and wild-type (WT) mice. Carnitine was supplemented orally for 4 weeks starting at 5 weeks of age. Non-supplemented animals served as controls. In vivo data were complemented with ex vivo biochemical assays. RESULTS: LCAD KO mice displayed cardiac hypertrophy and elevated levels of myocardial TG compared to WT mice. Carnitine supplementation lowered myocardial TG, normalizing myocardial TG levels in LCAD KO mice. Furthermore, carnitine supplementation did not affect cardiac performance and hypertrophy, or induce an accumulation of potentially toxic long-chain acylcarnitines in the LCAD KO heart. CONCLUSION: This study lends support to the proposed beneficial effect of carnitine supplementation alleviating toxicity by exporting acylcarnitines out of the FAO-deficient myocardium, rather than to the concern about a potentially detrimental effect of supplementation-induced production of lipotoxic long-chain acylcarnitines.
PURPOSE: Elevation of long-chain acylcarnitine levels is a hallmark of long-chain mitochondrial β-oxidation (FAO) disorders, and can be accompanied by secondary carnitine deficiency. To restore free carnitine levels, and to increase myocardial export of long-chain fatty acyl-CoA esters, supplementation of L-carnitine in patients has been proposed. However, carnitine supplementation is controversial, because it may enhance the potentially lipotoxic buildup of long-chain acylcarnitines in the FAO-deficient heart. In this longitudinal study, we investigated the effects of carnitine supplementation in an animal model of long-chain FAO deficiency, the long-chain acyl-CoA dehydrogenase (LCAD) knockout (KO) mouse. METHODS: Cardiac size and function, and triglyceride (TG) levels were quantified using proton magnetic resonance imaging (MRI) and spectroscopy ((1)H-MRS) in LCAD KO and wild-type (WT) mice. Carnitine was supplemented orally for 4 weeks starting at 5 weeks of age. Non-supplemented animals served as controls. In vivo data were complemented with ex vivo biochemical assays. RESULTS:LCAD KO mice displayed cardiac hypertrophy and elevated levels of myocardial TG compared to WT mice. Carnitine supplementation lowered myocardial TG, normalizing myocardial TG levels in LCAD KO mice. Furthermore, carnitine supplementation did not affect cardiac performance and hypertrophy, or induce an accumulation of potentially toxic long-chain acylcarnitines in the LCAD KO heart. CONCLUSION: This study lends support to the proposed beneficial effect of carnitine supplementation alleviating toxicity by exporting acylcarnitines out of the FAO-deficient myocardium, rather than to the concern about a potentially detrimental effect of supplementation-induced production of lipotoxic long-chain acylcarnitines.
Authors: Beth K Potter; Julian Little; Pranesh Chakraborty; Jonathan B Kronick; Jessica Evans; Julia Frei; Sarah C Sutherland; Kumanan Wilson; Brenda J Wilson Journal: J Inherit Metab Dis Date: 2011-06-01 Impact factor: 4.982
Authors: K B Cox; D A Hamm; D S Millington; D Matern; J Vockley; P Rinaldo; C A Pinkert; W J Rhead; J R Lindsey; P A Wood Journal: Hum Mol Genet Date: 2001-09-15 Impact factor: 6.150
Authors: M Liebig; M Gyenes; G Brauers; J P N Ruiter; U Wendel; E Mayatepek; A W Strauss; R J A Wanders; U Spiekerkoetter Journal: J Inherit Metab Dis Date: 2006 Apr-Jun Impact factor: 4.982
Authors: Malika Chegary; Heleen te Brinke; Jos P N Ruiter; Frits A Wijburg; Maria S K Stoll; Paul E Minkler; Michel van Weeghel; Horst Schulz; Charles L Hoppel; Ronald J A Wanders; Sander M Houten Journal: Biochim Biophys Acta Date: 2009-05-22
Authors: Chikara Otsubo; Sivakama Bharathi; Radha Uppala; Olga R Ilkayeva; Dongning Wang; Kevin McHugh; Ye Zou; Jieru Wang; John F Alcorn; Yi Y Zuo; Matthew D Hirschey; Eric S Goetzman Journal: J Biol Chem Date: 2015-08-03 Impact factor: 5.157
Authors: Christoph Juchem; Peter Herman; Basavaraju G Sanganahalli; Peter B Brown; Scott McIntyre; Terence W Nixon; Dan Green; Fahmeed Hyder; Robin A de Graaf Journal: NMR Biomed Date: 2014-05-17 Impact factor: 4.044
Authors: Anne-Claire M F Martines; Karen van Eunen; Dirk-Jan Reijngoud; Barbara M Bakker Journal: PLoS Comput Biol Date: 2017-04-03 Impact factor: 4.475
Authors: Nunya Chotiwan; Barbara G Andre; Irma Sanchez-Vargas; M Nurul Islam; Jeffrey M Grabowski; Amber Hopf-Jannasch; Erik Gough; Ernesto Nakayasu; Carol D Blair; John T Belisle; Catherine A Hill; Richard J Kuhn; Rushika Perera Journal: PLoS Pathog Date: 2018-02-15 Impact factor: 6.823
Authors: Pablo Ranea-Robles; Sara Violante; Carmen Argmann; Tetyana Dodatko; Dipankar Bhattacharya; Hongjie Chen; Chunli Yu; Scott L Friedman; Michelle Puchowicz; Sander M Houten Journal: Cell Mol Life Sci Date: 2021-06-10 Impact factor: 9.207